Selective estrogen receptor modulation (Enclomiphene): studied for its action at the hypothalamic-pituitary-gonadal axis
The regulatory nod is the first new frontline treatment for patients whose cancer is mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H) in decades, according to GSK
Instead, it becomes part of a larger recovery plan that may include specific spinal adjustments, digital x-ray analysis, spinal traction, laser therapy, or acupuncture
AI should enhance, not replace, clinical judgment
With lower up-front premiums, a potential employer contribution to an HSA, and an out-of-pocket maximum that caps catastrophic costs (as long as the plan's network is adequate), HDHPs can still be a compelling choice, even without the fixed copays offered by traditional health plans